species, there are found the
, similar speciesgrowing in the western part of the United States, often cultivated andmixed with the official.DESCRIPTION OF DRUG.—Rough, grayish-green fragments of theleaves, mixed with brownish-yellow stem fragments, and with flower-heads about 15 mm. (3/5 in.) in diameter, usually destitute of florets,leaving the
bare receptacle surrounded by the stiff, varnished,resinous bracts
of the involucre; odor balsamic; taste aromatic andbitter.
Distinction of the Two Species
.—It may be said that the two species,
, resemble each other very much.
is saidto have a more leafy involucre and the leaves to be more coarselyserrate. The
in general is said to be less leafy and bushy, buton close examination of numerous specimens it is a question whetherthe distinction will hold.
.—Characteristic elements: See Part iv, Chap. I, B.
CONSTITUENTS.—The medicinal properties of grindelia seem to residein
the resinous exudation
. An alkaloid principle has been claimed bysome investigators and termed grindeline.ACTION AND USES.—
Antispasmodic and sedative, in asthma
.Dose: 15 to 60 gr. (1 to 4 Gm.). The fluidextract is said to be an efficientapplication in rhus poisoning.
Dose: 15 to 60 drops (1 to 4 mils).577.
.—TANSY. The leaves and tops of
Linné.Off. in U.S.P. 1890 Leaves pinnate, the lobes sharply serrate, in wrinkled, brokenpieces mixed with the reddish stems; midrib heavy and prominent on under side; odorstrong, fragrant, diminished by drying; taste bitter, somewhat mint-like.Constituents: Tanacetin, C
(a bitter principle), malic acid, volatile Oil (0.25per cent.), tannin, resin, etc. Stimulant, tonic, emmenagogue, and anthelmintic. Thedose of the volatile oil is from 1 to 5 drops; used also as a domestic abortifacient andas a remedy for amenorrhea. Its use should be prohibited except upon physician'sorder, as it is a dangerous drug. Dose: 15 to 60 gr. (1 to 4 Gm.), in infusion.578.
.—WORMWOOD, N.F. The leaves and tops of
Linné. Off. U.S.P. 1890. Consists of the grayish, softly, hairy,
Sayre’s Materia Medica part VI - Page 3